Adakveo
- Licence status
- Withdrawn: 21/08/2023
- Active substances
- Crizanlizumab
- Dosage Form
- Concentrate for solution for infusion
- Licence number
- EU/1/20/1476/001
- Licence holder
- Novartis Europharm Limited
Licence information
- ATC code
- B06A OTHER HEMATOLOGICAL AGENTS, B06AX01 crizanlizumab
- Legal supply status
- Product subject to prescription which may not be renewed (A)
- Place of sale
- Supply through pharmacies only
- Conditions of Licence
- Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
- Marketing availability
- Unknown
- Advertising conditions
- Advertising to healthcare professionals only
- Licence issued
- 28/10/2020